C-peptide and long-term complications of diabetes

C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes

(2009) P. Luppi et al.   DIABETOLOGIA

Proinsulin C-peptide Regulates Ribosomal RNA Expression

(2009) Emma Lindahl et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The role of inflammation in insulitis and β-cell loss in type 1 diabetes

(2009) Décio L. Eizirik et al.   Nature Reviews Endocrinology

Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-κB activation in vascular smooth muscle cells

(2008) Vincenza Cifarelli et al.   ATHEROSCLEROSIS

Peroxisome Proliferator-Activated Receptor-γ–Mediated Effects in the Vasculature

(2008) Sheng Zhong Duan et al.   CIRCULATION RESEARCH

Fasting Plasma C-Peptide and Micro- and Macrovascular Complications in a Large Clinic-Based Cohort of Type 1 Diabetic Patients

(2008) F. Panero et al.   DIABETES CARE

Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-κB pathway

(2008) P. Luppi et al.   DIABETOLOGIA

Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism

(2007) Lina Nordquist et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats

(2007) Akihiro Kamikawa et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS